UNILEVERCL Stock Overview
Manufactures and markets consumer healthcare products in Bangladesh. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Unilever Consumer Care Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳2,605.20 |
| 52 Week High | ৳3,370.00 |
| 52 Week Low | ৳1,801.00 |
| Beta | 0.14 |
| 11 Month Change | -3.12% |
| 3 Month Change | -13.72% |
| 1 Year Change | 29.62% |
| 33 Year Change | 46.09% |
| 5 Year Change | 143.76% |
| Change since IPO | 3,315.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| UNILEVERCL | BD Food | BD Market | |
|---|---|---|---|
| 7D | 0.2% | 1.0% | -0.9% |
| 1Y | 29.6% | 6.3% | -20.0% |
Return vs Industry: UNILEVERCL exceeded the BD Food industry which returned 6.2% over the past year.
Return vs Market: UNILEVERCL exceeded the BD Market which returned -20% over the past year.
Price Volatility
| UNILEVERCL volatility | |
|---|---|
| UNILEVERCL Average Weekly Movement | 3.9% |
| Food Industry Average Movement | 7.6% |
| Market Average Movement | 7.0% |
| 10% most volatile stocks in BD Market | 9.3% |
| 10% least volatile stocks in BD Market | 3.9% |
Stable Share Price: UNILEVERCL has not had significant price volatility in the past 3 months compared to the BD market.
Volatility Over Time: UNILEVERCL's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 71 | Khan Salahuddin Minhaj | www.unileverconsumercarebd.com |
Unilever Consumer Care Limited manufactures and markets consumer healthcare products in Bangladesh. It offers health food drinks under the Horlicks, Maltova, and Boost brand names; and glucose powder under the GlucoMax D brand name. The company was formerly known as GlaxoSmithKline Bangladesh Limited and changed its name to Unilever Consumer Care Limited in August 2020.
Unilever Consumer Care Limited Fundamentals Summary
| UNILEVERCL fundamental statistics | |
|---|---|
| Market cap | ৳50.21b |
| Earnings (TTM) | ৳855.88m |
| Revenue (TTM) | ৳3.46b |
58.7x
P/E Ratio14.5x
P/S RatioIs UNILEVERCL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| UNILEVERCL income statement (TTM) | |
|---|---|
| Revenue | ৳3.46b |
| Cost of Revenue | ৳1.96b |
| Gross Profit | ৳1.50b |
| Other Expenses | ৳648.32m |
| Earnings | ৳855.88m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 44.41 |
| Gross Margin | 43.41% |
| Net Profit Margin | 24.70% |
| Debt/Equity Ratio | 20.4% |
How did UNILEVERCL perform over the long term?
See historical performance and comparison